Toshishige Y, Kondo M, Watanabe T, Yamada A, Hashimoto H, Okazaki J
PCN Rep. 2024; 2(2):e95.
PMID: 38868151
PMC: 11114357.
DOI: 10.1002/pcn5.95.
Solis E, Carlier I, Kamminga N, Giltay E, van Hemert A
Trials. 2024; 25(1):187.
PMID: 38481289
PMC: 10938802.
DOI: 10.1186/s13063-024-08033-9.
Koshikawa Y, Onohara A, Wakeno M, Takekita Y, Kinoshita T, Kato M
Heliyon. 2023; 9(10):e20917.
PMID: 37886758
PMC: 10597827.
DOI: 10.1016/j.heliyon.2023.e20917.
Alhemedi A, Qasaimeh M, Abdo N, Elsalem L, Qaadan D, Alomari E
Psychol Res Behav Manag. 2023; 16:4237-4249.
PMID: 37873060
PMC: 10590589.
DOI: 10.2147/PRBM.S436293.
Forman-Hoffman V, Pirner M, Flom M, Kirvin-Quamme A, Durden E, Kissinger J
JMIR Form Res. 2023; 7:e46473.
PMID: 37756047
PMC: 10568381.
DOI: 10.2196/46473.
Depression trajectories during the COVID-19 pandemic: a secondary analysis of the impact of cognitive-appraisal processes.
Schwartz C, Borowiec K, Rapkin B
J Patient Rep Outcomes. 2023; 7(1):67.
PMID: 37439964
PMC: 10344849.
DOI: 10.1186/s41687-023-00600-z.
Peripartum depression and its predictors: A longitudinal observational hospital-based study.
Hamed S, ElWasify M, Abdelhafez M, Fawzy M
World J Psychiatry. 2022; 12(8):1061-1075.
PMID: 36158302
PMC: 9476840.
DOI: 10.5498/wjp.v12.i8.1061.
Challenging Behavior and Parental Depression: The Effects of Everyday Stressors and Benefit Finding for Parents of Children with Autism Spectrum Disorder.
Vitale S, Schneider H, Gardner L, Alessandri M, Marker C
J Autism Dev Disord. 2022; 53(9):3356-3368.
PMID: 35749002
DOI: 10.1007/s10803-022-05627-7.
Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD): recruitment, retention, and data availability in a longitudinal remote measurement study.
Matcham F, Leightley D, Siddi S, Lamers F, White K, Annas P
BMC Psychiatry. 2022; 22(1):136.
PMID: 35189842
PMC: 8860359.
DOI: 10.1186/s12888-022-03753-1.
Gender Disparities in Symptoms of Depression After Medical School Exams and Student Coping Strategies for Postexam Depression Symptoms.
Arabatzis T, Marsidi J, Ashraf M, Supino C, Smith R
J Med Educ Curric Dev. 2022; 9:23821205211055391.
PMID: 35036564
PMC: 8753238.
DOI: 10.1177/23821205211055391.
Biological and clinical correlates of the patient health questionnaire-9: exploratory cross-sectional analyses of the baseline health study.
Califf R, Wong C, Doraiswamy P, Hong D, Miller D, Mega J
BMJ Open. 2022; 12(1):e054741.
PMID: 34983769
PMC: 8728408.
DOI: 10.1136/bmjopen-2021-054741.
Evidence and theory for lower rates of depression in larger US urban areas.
Stier A, Schertz K, Rim N, Cardenas-Iniguez C, Lahey B, Bettencourt L
Proc Natl Acad Sci U S A. 2021; 118(31).
PMID: 34315817
PMC: 8346882.
DOI: 10.1073/pnas.2022472118.
Persistent depressive disorder across the adult lifespan: results from clinical and population-based surveys in Germany.
Nubel J, Guhn A, Mullender S, Le H, Cohrdes C, Kohler S
BMC Psychiatry. 2020; 20(1):58.
PMID: 32041560
PMC: 7011512.
DOI: 10.1186/s12888-020-2460-5.
Metta-based group meditation and individual cognitive behavioral therapy (MeCBT) for chronic depression: study protocol for a randomized controlled trial.
Frick A, Thinnes I, Stangier U
Trials. 2020; 21(1):20.
PMID: 31907002
PMC: 6945547.
DOI: 10.1186/s13063-019-3815-4.
Remote assessment of disease and relapse in major depressive disorder (RADAR-MDD): a multi-centre prospective cohort study protocol.
Matcham F, Barattieri di San Pietro C, Bulgari V, de Girolamo G, Dobson R, Eriksson H
BMC Psychiatry. 2019; 19(1):72.
PMID: 30777041
PMC: 6379954.
DOI: 10.1186/s12888-019-2049-z.
Transitions through stages of alcohol involvement: The potential role of mood disorders.
Crum R, Green K, Stuart E, La Flair L, Kealhofer M, Young A
Drug Alcohol Depend. 2018; 189:116-124.
PMID: 29908411
PMC: 6557161.
DOI: 10.1016/j.drugalcdep.2018.02.027.
Population Base Rates and Disease Course of Common Psychiatric and Neurodegenerative Disorders.
Kitchen Andren K, Gabel N, Stelmokas J, Rich A, Bieliauskas L
Neuropsychol Rev. 2017; 27(3):284-301.
PMID: 28939959
DOI: 10.1007/s11065-017-9357-1.
Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder.
Connor K, Ceesay P, Hutzelmann J, Snavely D, Krystal A, Trivedi M
Int J Neuropsychopharmacol. 2017; 20(8):613-618.
PMID: 28582570
PMC: 5570043.
DOI: 10.1093/ijnp/pyx033.
Dietary inflammatory index and recurrence of depressive symptoms: Results from the Whitehall II Study.
Akbaraly T, Kerlau C, Wyart M, Chevallier N, Ndiaye L, Shivappa N
Clin Psychol Sci. 2017; 4(6):1125-1134.
PMID: 28070452
PMC: 5218819.
DOI: 10.1177/2167702616645777.
Patterns of depressive disorders across 13 years and their determinants among midlife women: SWAN mental health study.
Bromberger J, Kravitz H, Youk A, Schott L, Joffe H
J Affect Disord. 2016; 206:31-40.
PMID: 27455356
PMC: 5077630.
DOI: 10.1016/j.jad.2016.07.005.